Paxlovid-Induced Symptomatic Bradycardia and Syncope

Paxlovid (nirmatrelvir/ritonavir) is a game changer in the fight against COVID-19 due to its ease of administration and significant benefits of reducing progression to severe COVID-19, hospitalization, and death. Cardiac adverse events such as bradycardia and syncope are not known with this medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganipisetti, Venu M, Bollimunta, Pratyusha, Maringanti, Sriram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842109/
https://www.ncbi.nlm.nih.gov/pubmed/36655157
http://dx.doi.org/10.7759/cureus.33831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842109/
https://www.ncbi.nlm.nih.gov/pubmed/36655157
http://dx.doi.org/10.7759/cureus.33831

Ejemplares similares